Treatment of severe neuroleptic-induced tardive torticollis
Tóm tắt
The aim of this paper is to describe a case of severe neuroleptic-induced tardive torticollis successfully treated with a combination of clozapine, clonazepam and botulinum toxin-A. The patient, a 30-year old man with a seven-year history of delusional disorder experienced severe right torticollis with painful tightness of the neck and elevation of the shoulder. At this time he was receiving haloperidol 20 mg, trifluoperazine 5 mg, zuclopenthixol 20 mg and biperidine 4 mg daily. The combination therapy with clozapine and clonazepam and the long-term use of botulinum toxin-A resulted in a complete remission of dystonic movements. The present observations provide evidence indicating that this combination therapy may be of benefit in patients with severe neuroleptic-induced tardive torticollis.
Tài liệu tham khảo
Van Harten PN, Kahn RS: Tardive dystonia. Schizophrenia Bull. 1999, 25: 741-748.
Kiriakakis V, Bhatia KP, Marsden CD: The natural history of tardive dystonia: A long-term follow up of 107 cases. Brain. 1998, 121: 2053-2066. 10.1093/brain/121.11.2053.
Adityanjee , Adezibijde YA, Jampala C, Mathews T: The current status of tardive dystonia. Biol Psychiatry. 1999, 45: 715-730. 10.1016/S0006-3223(98)00242-X.
Burke RE, Fahn S, Jankovic J, Marsden CD, Lang AE, Gollomp S, Ilson J: Tardive dystonia : Late onset and persistent dystonia caused by antipsychoyic drugs. Neurology. 1982, 32: 1335-1346.
Tsui JKC, Eisen A, Stoessl AJ, Calne S, Calne DB: Duble-blind study of botulinum toxin in spasmodic torticollis. Lancet. 1986, 2: 245-246. 10.1016/S0140-6736(86)92070-2.
Overall JE, Gohram DR: The Brief Psychiatric Rating Scale. Psychol Rep. 1962, 10: 799-812.
Caine E, Polinsky R, Kartzinel R, Ebert M: Trial use of clozapine for abnormal movement disorders. Am J Psychiatry. 1979, 136: 317-320.
Lieberman J, Saltz B, John C, Pollak S, Borenstein M, Kane J: The effect of clozapine in tardive dyskinesia. Br J Psychiatry. 1991, 154: 503-510.
Adityanjee , Estrera AB: Successful treatment of tardive dystonia with clozapine. Biol Psychiatry. 1996, 39: 1064-1065. 10.1016/0006-3223(95)00633-8.
Lamberti JS, Bellnier T: Clozapine and tardive dystonia. J Nerv Ment Dis. 1993, 181: 137-138.
Van Harten PN, Kamphuis DJ, Matroos GE: Use of clozapine in tardive dystonia. Prog Neuro-Psychopharmacol & Biol Psychiatry. 1996, 20: 263-274. 10.1016/0278-5846(95)00309-6.
Freedman J: Clozapine treatment of psychosis in patients with tardive dystonia. Mov Disorders. 1994, 9: 321-324.
Trugman JM, Leadbetter R, Zalis ME: Treatment of several axial tardive dystonia with clozapine: case report and hypothesis. Mov Disorders. 1994, 9: 441-446.
Black LM, Marks RC, Nierman P, Luchins DJ: Clozapine and clonazepam in tardive dystonia. J Clin Psychopharmcol. 1991, 11: 268-269.
Shapleske J, Mckay AP, Makenna PJ: Successful treatment of tardive dystonia with clozapine and clonazepam. Br J Psychiatry. 1996, 168: 516-518.
Littrell KH, Johnson CG, Littrell S, Peabody CD: Marked reduction of tardive dyskinesia with olanzapine. Arch Gen Psychiatry. 1998, 55: 279-280. 10.1001/archpsyc.55.3.279.
Jaffe ME, Simpson GM: Reduction of tardive dystonia with olanzapine. Am J Psychiatry. 1999, 156: 2016-
Fukui H, Murai T: Marked improvement of Meige's Syndrome with olanzapine in a schizophrenic patient. J Neuropsychiatry Clin Neurosci. 2002, 14: 355-356. 10.1176/appi.neuropsych.14.3.355.
Moore P: Handbook of Botulinum Toxin Treatment. 1995, Cambridge, England: Blakwell Science Ltd
Tsuong D, Hermanowicz N, Rontal M: Botulinum toxin in treatment of tardive dyskinetic syndrome. J Clin Psychopharmacol. 1990, 6: 438-439.
Kaufman DM: Use of botulinum injections for spasmodic torticollis of tardive dystonia. J Neurochem Clin Neurosciences. 1994, 6: 50-53.
Chatterjee A, Forrest GM, Giladi N, Trosh R: Botulinum toxin in the treatment of tardive dystonia. J Clin Psychopharmacol. 1997, 17: 497-498. 10.1097/00004714-199712000-00016.
Tarsy D, Kaufman D, Sehti KD, Rivner ME, Molho E, Factor S: An open-label study of botulinum toxin A for treatment of tardive dystonia. Clin Neuropharmacol. 1997, 20: 90-93.